Selective serotonin reuptake inhibitor effects on neural biomarkers of perinatal depression
- 19 Downloads
The effect of perinatal selective serotonin reuptake inhibitors (SSRIs) on brain-derived neurotrophic factor (BDNF) and S100 calcium binding protein B (S100B) has not been investigated. Using a cohort of 86 pregnant women, we found that SSRIs significantly increase BDNF levels in late pregnancy and that S100B, but not BDNF, is associated with maternal depression in SSRI-treated women only. This shows that serum S100B could be a unique biomarker to determine efficacy of SSRIs during gestation.
KeywordsDepression Anxiety Antidepressants Gestation Motherhood Neuroplasticity
Compliance with ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- Gao X, Wang J, Yao H, Cai Y, Cheng R (2016) Serum BDNF concentration after delivery is associated with development of postpartum depression: a 3-month follow up study. J AffectDisord 200:25–30Google Scholar
- Guintivano J, Sullivan PF, Stuebe AM, Penders T, Thorp J, Rubinow DR, Meltzer-Brody S (2017) Adverse life events, psychiatric history, and biological predictors of postpartum depression in an ethnically diverse sample of postpartum women. Psychol Med:1–14Google Scholar
- Gupta K, Gupta R, Bhatia MS, Tripathi AK, Gupta LK (2017) Effect of agomelatine and fluoxetine on HAM-D score, serum brain-derived neurotrophic factor, and tumor necrosis factor-alpha level in patients with major depressive disorder with severe depression. J Clin Pharmacol 57:1519–1526CrossRefGoogle Scholar